Hands-On Insight: Powering a GTM Push in Regenerative Medicine

The Client

Our client is a leading contract development and manufacturing organization (CDMO) operating at the forefront of regenerative medicine. With a global reach and a mission to enhance patient outcomes, the company partners closely with Original Equipment Manufacturers (OEMs) to design and deliver biological materials that accelerate healing and reduce complications.

Their solutions are used in a range of specialized clinical segments—including plastic and reconstructive surgery, orthopedics, cardiac, and neurosurgery. As they continue to push the boundaries of tissue engineering and innovation, the client sought targeted support to strengthen their commercial strategy.

The Challenge

The company was launching a go-to-market optimization initiative focused on improving how they approached market entry and evaluated new opportunities. They needed a Life Science Consultant who could support diligence activities and contribute to data gathering, research, and analytics under the direction of senior team members.

Key responsibilities included:

• Assisting with commercial due diligence and market assessment
• Conducting quantitative and qualitative research
• Supporting data analytics efforts
• Helping validate strategic assumptions with external insights

The ideal candidate would be a former consultant from a top-tier firm with life sciences experience, particularly within medical devices, CDMO, or related segments. Just as important was a hands-on mindset—someone able to operate independently, move quickly, and add value across multiple workstreams with minimal oversight.

Our Approach

We focused our search on pre-MBA professionals from top consulting firms with relevant exposure to healthcare and life sciences, particularly in commercial strategy, M&A diligence, and market sizing.

We prioritized candidates who had not only experience working on strategic engagements for medical device or biotech companies, but also a clear ability to operate as an embedded resource—comfortable contributing to both data-heavy analysis and voice-of-customer research.

Given the client’s timeline and the need for flexibility, we looked for independent consultants with a “doer” mentality—someone who could roll up their sleeves and move fluidly between support functions and strategic thinking.

The Placement

We placed a consultant with over three years of independent strategy and M&A consulting experience, who had previously worked at a top-tier management consulting firm. Her experience included:

• Leading over a dozen large-scale due diligence engagements across healthcare, tech, industrials, and financial services
• Advising the head of M&A at a major medical device company on the acquisition of a pre-market cancer treatment device—including market sizing, provider interviews, and adoption forecasting
• Conducting post-acquisition and go-to-market strategy work for an aesthetics/injectables company
• Performing primary research with surgeons, oncologists, and executives to assess market readiness and product viability
• Supporting strategic validation through interviews with executives and venture investors across relevant sectors

Her ability to seamlessly integrate with the client team, gather nuanced insights, and independently own key deliverables made her a strong fit for the project’s evolving needs.

The Outcome

The consultant successfully supported the go-to-market initiative, contributing to diligence efforts, synthesizing research insights, and enhancing the team’s ability to assess commercial opportunity. Her flexible, hands-on approach allowed her to exceed expectations typically set for junior-level consultants—delivering both strategic value and executional support.

By bringing in specialized expertise tailored to the life sciences sector, the client was able to move forward with confidence—equipped with the market insight and analytical rigor needed to sharpen their commercial strategy.